Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
 Back to Profile

Gina Kruse

Concepts (221)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Smoking Cessation
16
2024
407
5.690
 Why?
Text Messaging
5
2023
149
2.480
 Why?
Smoking
8
2023
1459
1.760
 Why?
Early Detection of Cancer
6
2025
369
1.520
 Why?
Primary Health Care
7
2023
1641
1.370
 Why?
Tobacco Use
3
2022
61
1.130
 Why?
Smokers
4
2020
138
1.080
 Why?
Colorectal Neoplasms
4
2025
751
1.050
 Why?
Tobacco Use Cessation
2
2024
24
0.960
 Why?
Tobacco Use Disorder
3
2022
237
0.960
 Why?
Buprenorphine
2
2025
160
0.860
 Why?
Uterine Cervical Neoplasms
2
2024
232
0.860
 Why?
Postal Service
2
2020
32
0.850
 Why?
Massachusetts
7
2025
158
0.810
 Why?
Community Health Services
2
2015
227
0.770
 Why?
Laboratories
1
2023
109
0.770
 Why?
Electronic Nicotine Delivery Systems
4
2022
88
0.730
 Why?
United States Indian Health Service
2
2022
42
0.710
 Why?
Patient Discharge
3
2024
854
0.700
 Why?
Mentoring
1
2023
130
0.680
 Why?
Electronic Health Records
4
2016
974
0.670
 Why?
Alaska Natives
1
2022
138
0.640
 Why?
Papillomavirus Infections
1
2023
293
0.630
 Why?
Tobacco Products
1
2020
110
0.620
 Why?
Health Behavior
3
2022
740
0.600
 Why?
Delivery of Health Care
4
2023
889
0.580
 Why?
Community Health Centers
5
2025
57
0.570
 Why?
Rural Population
3
2024
517
0.550
 Why?
Humans
54
2025
128495
0.550
 Why?
Meaningful Use
1
2016
13
0.530
 Why?
Middle Aged
22
2025
30921
0.520
 Why?
Indians, North American
1
2022
599
0.510
 Why?
Comorbidity
2
2017
1541
0.480
 Why?
HIV Infections
7
2024
2711
0.480
 Why?
Motivation
2
2019
545
0.480
 Why?
Female
33
2025
68266
0.460
 Why?
Smoke-Free Policy
1
2014
13
0.460
 Why?
Opiate Substitution Treatment
3
2025
135
0.450
 Why?
Smoking Prevention
1
2015
163
0.450
 Why?
Telemedicine
2
2021
786
0.450
 Why?
Unnecessary Procedures
1
2014
48
0.450
 Why?
Male
29
2025
63043
0.440
 Why?
Adult
25
2025
35299
0.430
 Why?
Tobacco Smoking
2
2024
25
0.420
 Why?
Reimbursement, Incentive
1
2013
36
0.420
 Why?
Pilot Projects
5
2022
1568
0.420
 Why?
Program Development
1
2015
357
0.410
 Why?
Counseling
4
2024
384
0.410
 Why?
Health Equity
3
2024
82
0.390
 Why?
Colonoscopy
1
2014
235
0.390
 Why?
Tobacco Smoke Pollution
1
2014
229
0.370
 Why?
Documentation
1
2013
183
0.370
 Why?
Neoplasms
2
2023
2463
0.370
 Why?
Population Surveillance
1
2014
435
0.370
 Why?
Telephone
2
2023
166
0.370
 Why?
Anti-HIV Agents
2
2014
751
0.330
 Why?
Hospitalization
2
2021
2069
0.330
 Why?
Cross-Sectional Studies
8
2024
5045
0.310
 Why?
Referral and Consultation
2
2012
728
0.300
 Why?
Aged
12
2025
21974
0.280
 Why?
Opioid-Related Disorders
2
2025
482
0.270
 Why?
Students
2
2022
570
0.270
 Why?
Boston
3
2024
86
0.250
 Why?
United States
7
2024
13840
0.250
 Why?
South Africa
2
2024
192
0.240
 Why?
Feasibility Studies
2
2022
863
0.240
 Why?
Appointments and Schedules
2
2002
81
0.230
 Why?
Pandemics
3
2021
1477
0.230
 Why?
Occult Blood
1
2024
30
0.220
 Why?
Faculty
2
2022
135
0.220
 Why?
India
2
2024
170
0.220
 Why?
Patient Compliance
2
2012
560
0.220
 Why?
Mental Disorders
2
2002
1007
0.220
 Why?
Outpatients
2
2024
368
0.220
 Why?
Social Determinants of Health
2
2024
221
0.220
 Why?
Narcotic Antagonists
1
2025
161
0.210
 Why?
Vaginal Smears
1
2023
56
0.200
 Why?
Safety-net Providers
1
2024
109
0.200
 Why?
Mass Screening
3
2025
1146
0.200
 Why?
Papillomaviridae
1
2023
113
0.190
 Why?
Interrupted Time Series Analysis
1
2022
53
0.190
 Why?
Outpatient Clinics, Hospital
1
2002
82
0.190
 Why?
Medically Underserved Area
1
2022
84
0.190
 Why?
Treatment Refusal
1
2002
88
0.190
 Why?
Pain Management
1
2005
321
0.190
 Why?
Behavior Therapy
2
2022
236
0.190
 Why?
Student Run Clinic
1
2021
3
0.190
 Why?
Tuberculosis
1
2024
272
0.180
 Why?
Vaping
1
2022
53
0.180
 Why?
Patient Participation
1
2005
409
0.180
 Why?
Ambulatory Care
1
2024
504
0.170
 Why?
Education, Medical, Undergraduate
1
2023
176
0.170
 Why?
Developing Countries
2
2015
286
0.170
 Why?
Interviews as Topic
3
2019
715
0.170
 Why?
Longitudinal Studies
2
2020
2710
0.170
 Why?
Physician-Patient Relations
1
2005
530
0.170
 Why?
Medication Adherence
1
2025
558
0.170
 Why?
Community Networks
1
2020
56
0.170
 Why?
Education, Medical
1
2023
244
0.160
 Why?
Crisis Intervention
1
2019
33
0.160
 Why?
Analgesics, Opioid
2
2024
889
0.160
 Why?
Pain
1
2005
751
0.160
 Why?
Preventive Health Services
1
2020
145
0.150
 Why?
Cohort Studies
5
2025
5402
0.150
 Why?
Students, Medical
1
2023
315
0.150
 Why?
Nevirapine
2
2008
16
0.150
 Why?
Decision Making
1
2005
847
0.140
 Why?
Surveys and Questionnaires
4
2019
5371
0.140
 Why?
Organophosphonates
2
2008
92
0.140
 Why?
Randomized Controlled Trials as Topic
2
2022
1358
0.140
 Why?
Communication
1
2023
841
0.130
 Why?
Deoxycytidine
2
2008
163
0.130
 Why?
Caregivers
1
2024
813
0.130
 Why?
Prevalence
3
2024
2553
0.130
 Why?
Liver Transplantation
1
2024
800
0.130
 Why?
Pneumonia, Viral
1
2021
337
0.130
 Why?
Infectious Disease Transmission, Vertical
2
2008
170
0.130
 Why?
Texas
4
2005
227
0.130
 Why?
Diabetes Mellitus
1
2024
996
0.130
 Why?
Young Adult
5
2024
12349
0.130
 Why?
Adenine
2
2008
256
0.130
 Why?
Diffusion of Innovation
1
2016
96
0.120
 Why?
Focus Groups
2
2022
452
0.120
 Why?
Hypertension
1
2024
1236
0.120
 Why?
Qualitative Research
2
2019
1227
0.120
 Why?
Adolescent
7
2024
20304
0.120
 Why?
Allied Health Personnel
1
2015
42
0.120
 Why?
Community Health Workers
1
2015
55
0.120
 Why?
Health Surveys
1
2017
493
0.120
 Why?
Automobiles
1
2014
19
0.120
 Why?
Logistic Models
3
2017
1980
0.110
 Why?
Uganda
1
2014
72
0.110
 Why?
Residence Characteristics
2
2014
326
0.100
 Why?
Odds Ratio
3
2008
1019
0.100
 Why?
Colonic Polyps
1
2014
87
0.100
 Why?
Program Evaluation
2
2020
872
0.100
 Why?
Patient Admission
1
2014
182
0.100
 Why?
Health Services Accessibility
4
2024
901
0.100
 Why?
Research Design
1
2019
1036
0.100
 Why?
Stress, Psychological
1
2021
1064
0.100
 Why?
Managed Care Programs
1
2013
133
0.100
 Why?
Prospective Studies
3
2025
7069
0.100
 Why?
Hospitals, Psychiatric
2
2002
23
0.100
 Why?
Patient Acceptance of Health Care
3
2022
757
0.100
 Why?
Social Class
1
2014
258
0.100
 Why?
HIV-1
2
2008
834
0.100
 Why?
Nurses
1
2014
164
0.100
 Why?
Feedback
1
2012
159
0.090
 Why?
Emergency Service, Hospital
1
2022
1900
0.090
 Why?
Health Plan Implementation
1
2012
137
0.090
 Why?
Follow-Up Studies
2
2024
4874
0.090
 Why?
Quality Assurance, Health Care
1
2013
316
0.090
 Why?
Hospitals
1
2014
637
0.080
 Why?
Retrospective Studies
4
2022
14471
0.080
 Why?
Diabetes Mellitus, Type 2
1
2022
2433
0.070
 Why?
Reverse Transcriptase Inhibitors
1
2007
82
0.070
 Why?
Patient Care Team
1
2012
598
0.070
 Why?
Chronic Disease
1
2013
1692
0.070
 Why?
Drug Resistance, Viral
1
2007
110
0.070
 Why?
Renal Insufficiency
1
2008
148
0.070
 Why?
Anti-Retroviral Agents
1
2008
231
0.060
 Why?
Aged, 80 and over
4
2024
7057
0.060
 Why?
Risk Factors
2
2014
9737
0.060
 Why?
Insurance, Health
2
2005
267
0.060
 Why?
Regression Analysis
2
2005
982
0.060
 Why?
Pregnancy Complications, Infectious
1
2008
364
0.060
 Why?
Quality Improvement
1
2012
1097
0.060
 Why?
Insurance Coverage
2
2022
219
0.060
 Why?
Vaccination
2
2022
1346
0.050
 Why?
Drug Therapy, Combination
2
2022
1016
0.050
 Why?
Rural Health Services
1
2004
110
0.050
 Why?
Housing
1
2024
130
0.050
 Why?
Social Networking
1
2023
33
0.050
 Why?
Pragmatic Clinical Trials as Topic
1
2022
62
0.050
 Why?
Health Status
2
2005
747
0.050
 Why?
Mobile Health Units
1
2022
19
0.050
 Why?
Midwestern United States
1
2002
41
0.050
 Why?
Health Services for the Aged
1
2003
72
0.050
 Why?
Hospitals, University
1
2002
176
0.050
 Why?
Quality of Life
2
2022
2688
0.050
 Why?
Bupropion
1
2022
40
0.050
 Why?
Varenicline
1
2022
26
0.050
 Why?
Schools, Medical
1
2023
130
0.050
 Why?
Antiviral Agents
1
2007
711
0.050
 Why?
Stakeholder Participation
1
2022
77
0.050
 Why?
England
1
2021
72
0.050
 Why?
Continuity of Patient Care
1
2004
275
0.050
 Why?
Vulnerable Populations
1
2022
157
0.050
 Why?
Meals
1
2022
118
0.050
 Why?
HIV
1
2022
226
0.050
 Why?
Data Collection
1
2024
649
0.040
 Why?
Minority Groups
1
2022
250
0.040
 Why?
Poverty
1
2024
497
0.040
 Why?
Urban Population
1
2003
441
0.040
 Why?
Triage
1
2021
205
0.040
 Why?
Learning
1
2023
399
0.040
 Why?
Medicaid
1
2003
433
0.040
 Why?
Zambia
2
2008
55
0.040
 Why?
Treatment Outcome
1
2012
10162
0.040
 Why?
Medicare
1
2003
719
0.030
 Why?
Practice Guidelines as Topic
1
2025
1490
0.030
 Why?
Emtricitabine
2
2008
168
0.030
 Why?
Tenofovir
2
2008
231
0.030
 Why?
Curriculum
1
2023
910
0.030
 Why?
Child
2
2024
20805
0.020
 Why?
Case-Control Studies
1
2017
3339
0.020
 Why?
Socioeconomic Factors
2
2004
1212
0.020
 Why?
Chi-Square Distribution
1
2008
512
0.020
 Why?
Antiretroviral Therapy, Highly Active
1
2008
266
0.020
 Why?
Creatinine
1
2008
480
0.020
 Why?
Risk
1
2008
853
0.020
 Why?
Pregnancy
2
2008
6373
0.020
 Why?
Proportional Hazards Models
1
2008
1200
0.010
 Why?
Glomerular Filtration Rate
1
2008
684
0.010
 Why?
Health Status Indicators
1
2004
167
0.010
 Why?
Office Visits
1
2003
82
0.010
 Why?
Disease Progression
1
2008
2604
0.010
 Why?
Health Care Surveys
1
2003
558
0.010
 Why?
Biomarkers
1
2008
3893
0.010
 Why?
Infant, Newborn
1
2007
5740
0.010
 Why?
Health Knowledge, Attitudes, Practice
1
2004
1276
0.010
 Why?
Kruse's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (221) concept(s)
_
Co-Authors Expand Description
See all (5) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)